FDA Guidance on Considerations for Neurodevelopmental Safety Studies: Key Aspects
The new article describes in detail a specific approach to be applied when developing a follow-up plan.
The new article describes in detail a specific approach to be applied when developing a follow-up plan.
The article outlines the key aspects to be covered by the labeling used for contact lenses.
The final article of the cycle explains the specific metrics to be measured in the course of clinical studies in order to collect accurate and reliable information regarding the products in question.
The article highlights the key points related to specific types of clinical trials.
The article highlights the key points related to specific types of clinical trials.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report